Cardiac Autonomic Neuropathy — One-Liners

Cardiac Autonomic Neuropathy — 50 Rapid-Fire One-Liners

  1. Cardiac autonomic neuropathy is a diabetes-related dysfunction of sympathetic and parasympathetic cardiac innervation.
  2. Parasympathetic fibers are affected earlier than sympathetic fibers in CAN.
  3. Reduced heart rate variability is the earliest detectable marker of CAN.
  4. Resting tachycardia in CAN reflects vagal withdrawal, not sympathetic excess.
  5. Definite CAN requires at least two abnormal cardiovascular autonomic reflex tests.
  6. Ewing’s battery remains the gold-standard diagnostic test for CAN.
  7. CAN is an independent predictor of sudden cardiac death.
  8. QTc prolongation in CAN reflects heterogeneous ventricular repolarization.
  9. QT dispersion correlates with malignant ventricular arrhythmia risk.
  10. Silent myocardial ischemia in diabetes is primarily due to autonomic afferent dysfunction.
  11. CAN patients may fail to mount tachycardia during hypotension or stress.
  12. Orthostatic hypotension in CAN results from impaired baroreflex sensitivity.
  13. Advanced CAN produces a “fixed heart rate” phenomenon.
  14. CAN increases peri-operative cardiovascular instability.
  15. Spinal or epidural anesthesia can cause profound hypotension in CAN.
  16. Hypotension in CAN is often refractory to fluid loading alone.
  17. Vasodilatory anesthetic agents require caution in CAN patients.
  18. Loss of nocturnal heart rate dipping suggests autonomic dysfunction.
  19. Reduced SDNN on Holter monitoring indicates impaired autonomic tone.
  20. CAN is more prevalent in long-standing type 1 diabetes than type 2 diabetes.
  21. DCCT/EDIC demonstrated that intensive glycemic control reduces CAN incidence.
  22. Poor glycemic variability accelerates progression of CAN.
  23. CAN often coexists with other microvascular complications of diabetes.
  24. Exercise intolerance in CAN is due to impaired chronotropic response.
  25. CAN blunts blood pressure response during exercise testing.
  26. CAN patients may present with syncope without prodromal symptoms.
  27. Supine hypertension can coexist with orthostatic hypotension in CAN.
  28. β-blockers may worsen exercise intolerance in advanced CAN.
  29. CAN increases risk of peri-procedural myocardial ischemia during PCI.
  30. Lack of chest pain during ACS should raise suspicion of CAN.
  31. CAN alters circadian rhythm of heart rate and blood pressure.
  32. Reduced Valsalva ratio is an early parasympathetic abnormality in CAN.
  33. Abnormal heart rate response to deep breathing suggests CAN.
  34. CAN is associated with increased all-cause mortality in diabetics.
  35. CAN may present with unexplained intra-operative bradycardia or asystole.
  36. Phenylephrine is preferred over ephedrine for hypotension in CAN.
  37. CAN patients are prone to peri-induction hemodynamic collapse.
  38. Cardiac denervation explains reduced ischemic pain perception in CAN.
  39. CAN severity correlates poorly with HbA1c at a single time point.
  40. CAN is often clinically silent until advanced stages.
  41. CAN impairs coronary blood flow regulation during stress.
  42. Fixed heart rate in CAN mimics pacemaker physiology.
  43. CAN increases risk of silent ventricular arrhythmias.
  44. Absence of heart rate recovery after exercise suggests CAN.
  45. CAN should be considered in diabetics with unexplained ECG abnormalities.
  46. Autonomic dysfunction worsens prognosis after myocardial infarction.
  47. CAN contributes to nocturnal sudden death syndrome in diabetes.
  48. CAN may exaggerate hypotensive response to nitrates.
  49. Screening for CAN is recommended in long-standing diabetes.
  50. CAN represents a marker of advanced systemic diabetic neuropathy.

Next add-ons I can generate immediately (same style):

  • Q21–Q40 ultra-brutal MCQs (ECG + cath lab + anesthesia)
  • One-page CAN peri-operative management table
  • ECG strip–based CAN quiz (image-driven)
  • 60 ultra-short one-liners (single clause each)

Tell me what to build next.

60 FAQs 5 points each

Below are 60 high-yield FAQs on Cardiac Autonomic Neuropathy (CAN), each answered in exactly 5 concise exam-oriented points, structured for DM / NEET-SS final revision, peri-operative viva, and cardiology boards.


Cardiac Autonomic Neuropathy — 60 FAQs (5 Points Each)


1. What is Cardiac Autonomic Neuropathy?

  • Diabetes-related autonomic nerve damage
  • Affects cardiac sympathetic and parasympathetic fibers
  • Leads to HR and BP dysregulation
  • Often clinically silent initially
  • Strong predictor of mortality

2. Which autonomic division is affected first in CAN?

  • Parasympathetic fibers first
  • Early vagal withdrawal
  • Causes resting tachycardia
  • HRV reduction appears early
  • Sympathetic loss occurs later

3. What is the epidemiology of CAN?

  • Seen in type 1 and type 2 diabetes
  • Prevalence increases with duration
  • Up to 60% in long-standing T2DM
  • Often underdiagnosed
  • Present even in prediabetes

4. What are the main pathogenic mechanisms?

  • Chronic hyperglycemia
  • Oxidative stress
  • Advanced glycation end products
  • Microvascular ischemia
  • Mitochondrial dysfunction

5. Why is CAN considered dangerous?

  • Independent mortality predictor
  • Causes silent ischemia
  • Increases sudden cardiac death risk
  • Leads to peri-operative instability
  • Often asymptomatic

6. What is the earliest objective marker of CAN?

  • Reduced heart rate variability
  • Abnormal deep breathing test
  • Early parasympathetic dysfunction
  • Appears before symptoms
  • Detected on Holter analysis

7. What are early clinical features of CAN?

  • Resting tachycardia
  • Reduced exercise tolerance
  • Blunted HR response to stress
  • Fatigue
  • Reduced HR variability

8. What are late clinical features of CAN?

  • Fixed heart rate
  • Orthostatic hypotension
  • Syncope
  • Silent MI
  • Sudden cardiac death

9. What is the gold standard diagnostic method?

  • Cardiovascular autonomic reflex tests
  • Ewing’s battery
  • Parasympathetic and sympathetic testing
  • Reproducible and validated
  • Predicts prognosis

10. What tests assess parasympathetic function?

  • Heart rate response to deep breathing
  • Valsalva ratio
  • 30:15 ratio on standing
  • Beat-to-beat RR variation
  • Early abnormality in CAN

11. What tests assess sympathetic function?

  • BP response to standing
  • BP response to handgrip
  • Tilt-table testing
  • Late abnormality
  • Predicts severe CAN

12. How is CAN staged (Ewing classification)?

  • Early: one abnormal parasympathetic test
  • Definite: ≥2 parasympathetic abnormalities
  • Severe: sympathetic involvement
  • Progressive disorder
  • Prognostic significance

13. Why does CAN cause resting tachycardia?

  • Loss of vagal tone
  • Parasympathetic denervation
  • Unopposed intrinsic SA rate
  • Not due to sympathetic excess
  • Early clinical sign

14. Why does CAN cause orthostatic hypotension?

  • Baroreflex failure
  • Impaired vasoconstriction
  • Sympathetic denervation
  • No compensatory tachycardia
  • Poor response to fluids

15. How does CAN differ from hypovolemia?

  • HR response is blunted
  • Fluids have limited effect
  • BP instability persists
  • Autonomic tests abnormal
  • Chronic rather than acute

16. Why is silent ischemia common in CAN?

  • Afferent autonomic dysfunction
  • Loss of pain perception
  • Altered ischemic signaling
  • Delayed presentation
  • Worse outcomes

17. How does CAN affect exercise physiology?

  • Chronotropic incompetence
  • Blunted BP rise
  • Early fatigue
  • Reduced VO₂ max
  • Normal LV systolic function

18. What ECG findings suggest CAN?

  • Reduced HR variability
  • Fixed RR intervals
  • QTc prolongation
  • Increased QT dispersion
  • Loss of circadian variation

19. Why is QT prolongation dangerous in CAN?

  • Repolarization heterogeneity
  • Increased ventricular arrhythmias
  • No autonomic buffering
  • Nocturnal vulnerability
  • Sudden death risk

20. What is the relationship between CAN and sudden death?

  • Strong independent association
  • Often nocturnal
  • Linked to QT abnormalities
  • Arrhythmia-mediated
  • Occurs even without CAD

21. How does CAN increase peri-operative risk?

  • Unpredictable hypotension
  • Bradycardia or asystole
  • Poor response to stress
  • Masked ischemia
  • High anesthesia sensitivity

22. Why is spinal anesthesia risky in CAN?

  • Sudden sympathetic blockade
  • No compensatory vasoconstriction
  • Profound hypotension
  • Refractory to fluids
  • Requires vasopressors

23. Which anesthetic drugs are problematic in CAN?

  • Vasodilators
  • Nitrates
  • Adenosine
  • High-dose propofol
  • Neuraxial agents

24. What vasopressors are preferred in CAN?

  • Direct alpha agonists
  • Phenylephrine
  • Midodrine
  • Norepinephrine (careful)
  • Avoid indirect agents

25. Why is ephedrine less effective in CAN?

  • Requires intact sympathetic nerves
  • Autonomic denervation present
  • Reduced norepinephrine release
  • Poor BP response
  • Unreliable effect

26. How does CAN affect PCI procedures?

  • Exaggerated hypotension
  • Poor tolerance to vasodilators
  • Silent ischemia
  • Bradyarrhythmias
  • Higher peri-procedural risk

27. Why is HRV prognostically important?

  • Reflects autonomic balance
  • Predicts mortality
  • Detects subclinical CAN
  • Better than symptoms
  • Independent risk marker

28. What Holter parameters indicate CAN?

  • Low SDNN
  • Reduced RMSSD
  • Reduced LF and HF power
  • Loss of circadian variation
  • Fixed heart rate

29. How does CAN affect circadian rhythm?

  • Loss of nocturnal HR dipping
  • Blunted BP dipping
  • Night-time arrhythmias
  • Increased sudden death risk
  • Autonomic imbalance

30. What is the relationship between CAN and nephropathy?

  • Often coexist
  • Marker of microvascular disease
  • Shared pathophysiology
  • Worse prognosis together
  • Indicates advanced diabetes

31. How does glycemic control influence CAN?

  • Intensive control reduces incidence
  • Most benefit early
  • Limited reversal once advanced
  • Glycemic variability important
  • DCCT/EDIC evidence

32. Can CAN be reversed?

  • Early stages partially reversible
  • Advanced stages largely irreversible
  • Glycemic control slows progression
  • Symptom control possible
  • Prognosis still guarded

33. When should screening for CAN be done?

  • T1DM after 5 years
  • T2DM at diagnosis
  • Earlier if symptoms present
  • Annually in high-risk patients
  • Before major surgery

34. Why are symptoms unreliable in CAN?

  • Often asymptomatic
  • Poor symptom perception
  • Advanced disease may be silent
  • Objective testing required
  • Symptoms lag behind pathology

35. How does CAN affect blood pressure variability?

  • Increased variability
  • Orthostatic drops
  • Supine hypertension
  • Poor stress response
  • Prognostic significance

36. What is supine hypertension in CAN?

  • Elevated BP when supine
  • Coexists with orthostatic hypotension
  • Due to autonomic imbalance
  • Limits treatment options
  • Marker of severe CAN

37. How does CAN affect MI presentation?

  • Painless or atypical
  • Delayed diagnosis
  • Larger infarcts
  • Higher mortality
  • Poor warning signs

38. What is the role of tilt-table testing?

  • Evaluates severe autonomic failure
  • Assesses orthostatic intolerance
  • Differentiates syncope causes
  • Advanced diagnostic tool
  • Not screening test

39. How does CAN affect baroreflex sensitivity?

  • Markedly reduced
  • Central mechanism of hypotension
  • Explains anesthesia instability
  • Predicts mortality
  • Core pathophysiologic defect

40. Why is CAN often missed clinically?

  • Asymptomatic course
  • Overlap with other conditions
  • Lack of routine screening
  • Requires specialized testing
  • Under-recognized risk

41. How does CAN affect heart rate recovery after exercise?

  • Delayed recovery
  • Parasympathetic dysfunction
  • Predicts mortality
  • Simple screening marker
  • Reflects autonomic reserve

42. What is the significance of fixed heart rate?

  • Loss of autonomic modulation
  • Advanced CAN
  • Mimics pacemaker rhythm
  • Poor stress adaptability
  • High-risk feature

43. How does CAN differ from cardiomyopathy?

  • Primary autonomic dysfunction
  • Normal myocardial structure
  • Disproportionate instability
  • Preserved EF often
  • Autonomic tests abnormal

44. What role do ACE inhibitors play?

  • Improve endothelial function
  • Reduce microvascular damage
  • Cardioprotective
  • Indirect benefit on CAN
  • No direct reversal

45. Do SGLT2 inhibitors improve CAN?

  • Reduce CV events
  • Improve autonomic balance indirectly
  • Lower glycemic variability
  • Reduce HF risk
  • No direct CAN reversal proven

46. How does CAN influence arrhythmia risk?

  • Increases ventricular arrhythmias
  • QT prolongation
  • Loss of autonomic buffering
  • Night-time vulnerability
  • Sudden death mechanism

47. Why is CAN important before surgery?

  • Predicts hemodynamic collapse
  • Guides anesthesia choice
  • Influences monitoring intensity
  • Alters vasopressor strategy
  • Reduces peri-operative mortality

48. What monitoring is essential in advanced CAN?

  • Continuous invasive BP
  • ECG with QT monitoring
  • Volume status assessment
  • Close post-op observation
  • Autonomic awareness

49. How does CAN affect prognosis after MI?

  • Higher mortality
  • More arrhythmias
  • Silent ischemia
  • Poor autonomic recovery
  • Independent risk factor

50. Why is CAN considered a systemic marker?

  • Reflects widespread neuropathy
  • Associated with nephropathy and retinopathy
  • Indicates advanced diabetes
  • Predicts global vascular risk
  • Poor long-term outcomes

51. How does CAN affect BP response to nitrates?

  • Exaggerated hypotension
  • Lack of reflex tachycardia
  • Increased syncope risk
  • Requires cautious dosing
  • Clinical warning sign

52. What is the role of compression stockings?

  • Reduce venous pooling
  • Improve orthostatic tolerance
  • Non-pharmacologic therapy
  • Adjunctive measure
  • Useful in daily activities

53. Why are fluids alone insufficient in CAN hypotension?

  • Vasoconstriction failure
  • Autonomic denervation
  • Persistent venous pooling
  • Need for vasopressors
  • Central mechanism

54. How does CAN affect stress response?

  • Blunted catecholamine release
  • Impaired HR and BP rise
  • Poor adaptation to illness
  • Increased shock risk
  • High peri-procedural risk

55. What is the relationship between CAN and age?

  • Prevalence increases with age
  • Independent of duration
  • Age-related autonomic decline adds risk
  • Worse prognosis in elderly
  • Screening important

56. Can CAN occur without peripheral neuropathy?

  • Yes
  • Independent progression possible
  • May precede other neuropathies
  • Requires targeted testing
  • Often overlooked

57. How does CAN affect mortality compared to CAD?

  • Comparable risk magnitude
  • Independent of CAD severity
  • Adds incremental risk
  • Often underappreciated
  • Prognostically powerful

58. What is the most important reason to diagnose asymptomatic CAN?

  • Risk stratification
  • Peri-operative planning
  • Sudden death prevention
  • Tailored therapy
  • Improved outcomes

59. What is the single most important teaching point about CAN?

  • It is common, silent, and lethal
  • Early detection matters
  • HRV is key marker
  • Symptoms are unreliable
  • Prognosis-driven diagnosis

60. What best summarizes CAN in one line?

  • CAN is a silent autonomic disorder in diabetes that markedly increases cardiovascular and peri-operative mortality.

    Subscribe Medicine Question BankWhatsApp Channel

    FREE Updates, MCQs & Questions For Doctors & Medical Students

      Medicine Question Bank